Vanguard Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,157,552
| Closed | -$313M | – | 4638 |
|
|
2022
Q2 | $313M | Buy |
4,157,552
+244,424
| +6% | +$18.4M | 0.01% | 1147 |
|
|
2022
Q1 | $105M | Buy |
3,913,128
+35,789
| +0.9% | +$961K | ﹤0.01% | 1908 |
|
|
2021
Q4 | $185M | Buy |
3,877,339
+10,002
| +0.3% | +$477K | ﹤0.01% | 1660 |
|
|
2021
Q3 | $257M | Buy |
3,867,337
+165,770
| +4% | +$11M | 0.01% | 1442 |
|
|
2021
Q2 | $289M | Buy |
3,701,567
+9,027
| +0.2% | +$704K | 0.01% | 1388 |
|
|
2021
Q1 | $349M | Buy |
3,692,540
+252,080
| +7% | +$23.8M | 0.01% | 1206 |
|
|
2020
Q4 | $419M | Buy |
3,440,460
+563,000
| +20% | +$68.6M | 0.01% | 976 |
|
|
2020
Q3 | $251M | Buy |
2,877,460
+94,277
| +3% | +$8.24M | 0.01% | 1126 |
|
|
2020
Q2 | $180M | Buy |
2,783,183
+695,062
| +33% | +$44.9M | 0.01% | 1334 |
|
|
2020
Q1 | $93.3M | Buy |
2,088,121
+122,887
| +6% | +$5.49M | ﹤0.01% | 1568 |
|
|
2019
Q4 | $122M | Buy |
1,965,234
+1,242,668
| +172% | +$77.4M | ﹤0.01% | 1660 |
|
|
2019
Q3 | $27.2M | Buy |
722,566
+287,386
| +66% | +$10.8M | ﹤0.01% | 2325 |
|
|
2019
Q2 | $17.7M | Buy |
+435,180
| New | +$17.7M | ﹤0.01% | 2575 |
|